Why is Ambalal Sarabhai falling/rising?

As of 01-Aug, Ambalal Sarabhai Enterprises Ltd is experiencing a decline in its stock price, currently at Rs 32.97, which reflects a decrease of Rs 0.13 or 0.39%. The stock has recently fallen after three consecutive days of gains and is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock is close to its 52-week low, being only 4.09% away from Rs 31.62. Over the past year, the stock has generated a return of -52.22%, significantly underperforming the BSE500 index, which has seen a decline of only 1.55% during the same period. Despite an increase in profits by 81.9%, the stock's weak long-term fundamentals, including a low Return on Capital Employed (ROCE) of 2.3 and poor sales growth, contribute to its negative performance. In the broader market context, the stock has outperformed its sector by 2.77% today, but this is overshadowed by its overall poor performance in comparison to the benchmark Sensex, which has declined by 1.06% over the past week. The pharmaceuticals and drugs sector, in which Ambalal Sarabhai operates, has also seen a drop of 3.27%. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 56.45% against the 5-day average, indicating reduced interest in the stock. This combination of weak fundamentals, declining investor engagement, and sector-wide challenges suggests that the stock's price is under pressure, contributing to its current downward trend.